Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 12 , ISSUE 3 ( July-September, 2023 ) > List of Articles


A Case of Organizing Pneumonia in a Crohn's Disease Patient

Vishnu Gireesh, Sneha Tirpude, Nitin Pai, Sahil Rasane

Keywords : Case report, Crohn's disease, Cryptogenic organizing pneumonia, Inflammatory bowel disease, Pulmonary manifestations

Citation Information : Gireesh V, Tirpude S, Pai N, Rasane S. A Case of Organizing Pneumonia in a Crohn's Disease Patient. Indian J Respir Care 2023; 12 (3):277-280.

DOI: 10.5005/jp-journals-11010-1066

License: CC BY-NC-SA 4.0

Published Online: 30-10-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Introduction: Extraintestinal manifestations, including pulmonary manifestations like organizing pneumonia (OP), may be the presenting complaints in inflammatory bowel disease (IBD). In this case study, we discuss a case of OP in Crohn's disease to understand the pulmonary manifestation of IBD and its management. Case description: A 33-year-old female came with complaints of cough with minimal expectoration, headache, vomiting for 4 days, and dyspnea on exertion for 1 day. The patient has been a known case of Crohn's disease for the past 5 years. The patient had no history of smoking. High-resolution computed tomography (HRCT) thorax done on admission showed ground glass opacities and peribronchovascular interstitial thickening in the left lung, predominantly the left lower lobe. Transbronchial lung biopsy (TBLB) was done, and histopathology was suggestive of OP. The patient improved clinically and radiologically with steroids. Conclusion: Pulmonary manifestations of IBD are reported in numerous case studies. A patient with Crohn's disease presenting with respiratory symptoms should be carefully evaluated for infective etiology since patients are on immunosuppressants. Drug-induced lung disease is the most frequent pulmonary complication of IBD. OP is a rare manifestation of Crohn's disease, which requires careful evaluation, including bronchoscopy and biopsy, for diagnosis and management.

PDF Share
  1. Rankin GB, Watts HD, Melnyk CS, et al. National cooperative Crohn's disease study: extraintestinal manifestations and perianal complications. Gastroenterology 1979;77(4 Pt 2):914–920.
  2. Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003;9(2):104–115. DOI: 10.1097/00054725-200303000-00004
  3. Majewski S, Piotrowski W. Pulmonary manifestations of inflammatory bowel disease. Arch Med Sci 2015;11(6):1179–1188. DOI: 10.5114/aoms.2015.56343
  4. Tejeda Taveras N, Rivera Martinez A, Kumar R, et al. Pulmonary manifestations of inflammatory bowel disease. Cureus 2021;13(3):e14216. DOI: 10.7759/cureus.14216
  5. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996;23(1):29–34. DOI: 10.1097/00004836-199607000-00009
  6. Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011;7(4):235–241.
  7. Isaacs KL. How prevalent are extraintestinal manifestations at the initial diagnosis of IBD? Inflamm Bowel Dis. 2008;14(Suppl 2):S198–S199. DOI: 10.1002/ibd.20597
  8. Mahadeva R, Walsh G, Flower CD, et al. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000;15(1):41–48. DOI: 10.1183/09031936.00.15104100
  9. Hites M, Goicoechea Turcott EW, Taccone FS. The role of galactomannan testing to diagnose invasive pulmonary aspergillosis in critically ill patients. Ann Transl Med 2016;4(18):353. DOI: 10.21037/atm.2016.08.32
  10. Boonsarngsuk V, Niyompattama A, Teosirimongkol C, et al. False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics. Scand J Infect Dis 2010;42(6–7):461–468. DOI: 10.3109/00365541003602064
  11. Wu Z, Wang L, Tan L, et al. Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients. Diagn Microbiol Infect Dis 2021;99(4):115274. DOI: 10.1016/j.diagmicrobio.2020.115274
  12. Sehgal IS, Dhooria S, Choudhary H, et al. Utility of serum and bronchoalveolar lavage fluid galactomannan in diagnosis of chronic pulmonary aspergillosis. J Clin Microbiol 2019;57(3). DOI: 10.1128/JCM.01821-18
  13. Cordier JF. Cryptogenic organising pneumonia. Eur Respir J 2006;28(2):422–446. DOI: 10.1183/09031936.06.00013505
  14. Franks TJ, Galvin JR. Cryptogenic organizing pneumonia. Pulmonary Pathology 2018;137–140. DOI: 10.1007/978-3-319-69263-0_398
  15. Radzikowska E, Wiatr E, Langfort R, et al. Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-observational study. PLoS One 2017;12(9):e0184739. DOI: 10.1371/journal.pone.0184739
  16. Lazor R, Vandevenne A, Pelletier A, et al. Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles “Orphelines” Pulmonaires (GERM”O”P). Am J Respir Crit Care Med 2000;162(2 Pt 1):571–577. DOI: 10.1164/ajrccm.162.2.9909015
  17. King TE Jr, Mortenson RL. Cryptogenic organizing pneumonitis. The North American experience. Chest 1992;102(1 Suppl):8S–13S.
  18. Epler GR. Heterogeneity of bronchiolitis obliterans organizing pneumonia. Curr Opin Pulm Med 1998;4(2):93–97. DOI: 10.1097/00063198-199803000-00006
  19. Tanida S, Takemura M, Mizoshita T, et al. Organizing pneumonia in a patient with quiescent Crohn's disease. Case Rep Gastrointest Med 2016;2016:8129864. DOI: 10.1155/2016/8129864
  20. Basseri B, Enayati P, Marchevsky A, et al. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J Crohns Colitis 2010;4:390–390. DOI: 10.1016/j.crohns.2010.03.008
  21. Schwaiblmair M, Behr W, Haeckel T, et al. Drug induced interstitial lung disease. Open Respir Med J 2012;6(1):63–74. DOI: 10.2174/1874306401206010063
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.